Abbott Laboratories (ABT) Holdings Trimmed by State of Wisconsin Investment Board

Jeannie Matthews
January 13, 2018

DLGNF's SI was 335,900 shares in January as released by FINRA.

Bartlett & Co decreased Intel Corp (NASDAQ:INTC) stake by 11,753 shares to 751,774 valued at $28.63 million in 2017Q3. With 8.63 million avg volume, 3 days are for Viacom Class B (NASDAQ:VIAB)'s short sellers to cover VIAB's short positions. The stock decreased 0.59% or $0.25 during the last trading session, reaching $42.47. About shares traded. Dialog Semiconductor Plc (OTCMKTS:DLGNF) has 0.00% since January 11, 2017 and is. It has underperformed by 17.33% the S&P500.

Hm Payson & Company decreased its stake in Abbott Laboratories (ABT) by 14.68% based on its latest 2017Q3 regulatory filing with the SEC.

TRADEMARK VIOLATION WARNING: "Abbott Laboratories (ABT) Stock Rating Upgraded by Morgan Stanley" was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. They are projecting Next Quarter growth of 16.7%. Abbott Labs now has $102.56 billion valuation. Among active positions in the latest quarter, 624 holders increased their positions by a total of 64.76 million shares, 781 holders decreased the positions by a total of 52.73 million shares, and 243 holders held their positions. About 154,169 shares traded.

At the moment, the 50-day moving average of Abbott Laboratories (ABT) stock is at $55.91 while that of the 200 day is now reading $50.33, their 5-day, on the other hand, is at $58.87. It has underperformed by 0.80% the S&P500. Eminence Capital Lp who had been investing in Cyberark Software Ltd for a number of months, seems to be bullish on the $1.48B market cap company. It operates through four divisions: Mobile Systems, Automotive & Industrial, Connectivity, and Power Conversion. It has a 47.55 P/E ratio. The firm offers power management products, including PMICs, PMIC and audio, sub PMICs, and chargers; wireless connectivity solutions, such as Bluetooth low energy solutions, home automation solutions, and wireless and voice IC solutions for DECT and 2.4 GHz radio frequency bands; and audio chips comprising audio codecs, PMIC and audio, audio amplifiers, wireless audio, and USB audio solutions.

Manchester City rejects Arsenal's price on Alexis Sanchez
Sanchez is reportedly a target for arch rivals Manchester City and Manchester United and could even leave this month. Arsenal manager Arsene Wenger gave an update on the 29-year-old's status in a news conference Friday .

N.Korea 'likely' to join Winter Games
Trying to divine Kim's thinking from North Korean propaganda broadcasts is about as unrewarding as deconstructing Trump's tweets . The Korean War ended in an armistice in 1953, meaning that the two nations are technically still at war.

Lennar (NYSE:LEN) PT Set at $60.00 by Wedbush
As per Tuesday, March 22, the company rating was initiated by Evercore. (NASDAQ:MOBL) on Friday, July 15 to "Underweight" rating. Ruffer Llp decreased its stake in Lennar Corp ( LEN ) by 62.17% based on its latest 2017Q3 regulatory filing with the SEC.

Analysts await CF Industries Holdings, Inc. Therefore 94% are positive. Assurant had 10 analyst reports since July 30, 2015 according to SRatingsIntel. (NYSE:CF) rating on Wednesday, July 12. The firm has "Neutral" rating given on Tuesday, December 20 by Credit Suisse. As per Tuesday, September 5, the company rating was maintained by Jefferies. The company was maintained on Friday, July 21 by Deutsche Bank.

Abbott Laboratories (ABT) will report its next earnings on Jan 24 BMO.

The company reported its last earnings Actual EPS of $0.66/share. While talking about Performance of the Stock, Abbott Laboratories now has a Weekly performance of 0.22%, monthly performance percentage is 7.73 percent, Quarterly performance is 7.79 percent, 6 months performance shows a percent value of 22.37% and Yearly Performance is 44.62 percent. Therefore 33% are positive. According to these analysts, the Low Revenue Estimate for Abbott Laboratories is 7.29 Billion and the High Revenue Estimate is 7.49 Billion. ValuEngine cut Abbott Laboratories from a "buy" rating to a "hold" rating in a research report on Friday, December 1st. Edward Jones upgraded the stock to "Buy" rating in Tuesday, June 21 report. The stock of Abbott Laboratories (NYSE:ABT) has "Overweight" rating given on Thursday, October 19 by Barclays Capital. Oppenheimer maintained it with "Buy" rating and $203.0 target in Tuesday, August 29 report. Robert W. Baird maintained the stock with "Buy" rating in Thursday, November 16 report. BMO Capital Markets maintained the stock with "Hold" rating in Monday, July 10 report. The rating was downgraded by Morgan Stanley on Monday, January 4 to "Equal-Weight". Following the completion of the transaction, the executive vice president now owns 142,082 shares of the company's stock, valued at $7,986,429.22. Indiana Tru Invest owns 18,798 shares for 0.48% of their portfolio.

Since August 1, 2017, it had 0 buys, and 6 sales for $22.86 million activity. Bracken Sharon J sold $98,323 worth of stock. Salvadori Daniel Gesua Sive sold 28,319 shares worth $1.56M. The insider Contreras Jaime sold $2.74 million. Winfield Associates Inc. now owns 2,382 shares of the healthcare product maker's stock worth $116,000 after acquiring an additional 89 shares in the last quarter.

Short interest is another tool that analysts use to gauge investor sentiment. Its down 0.16, from 1.15 in 2017Q2. It turned negative, as 47 investors sold Abbott Laboratories shares while 563 reduced holdings. Heritage Trust Co raised its position in shares of Abbott Laboratories by 10.1% in the 2nd quarter. Fiera Cap Corp reported 21,438 shares or 0.01% of all its holdings. Jefferies maintained Abbott Laboratories (NYSE:ABT) rating on Thursday, August 4. Tower Bridge Advsrs holds 0.18% or 8,519 shares. Vanguard Gru Inc Inc holds 0.33% of its portfolio in Abbott Laboratories (NYSE:ABT) for 131.80 million shares. Checchi Capital Advisers Ltd Liability owns 3,153 shares for 0.31% of their portfolio. Westwood Holdings Group Inc. bought a new position in Abbott Laboratories during the second quarter worth approximately $162,264,000. Family Firm Incorporated reported 1,088 shares or 0.08% of all its holdings. 200 were reported by Capital Guardian Trust. Fincl Architects holds 0.02% or 70 shares in its portfolio. Cambridge Research Advsr has invested 0.13% in Abbott Laboratories (NYSE:ABT). Lynch Assoc In stated it has 1.15% of its portfolio in Abbott Laboratories (NYSE:ABT). Natl Registered Advisor owns 12,355 shares or 0.33% of their United States portfolio. D L Carlson Invest Grp has invested 0.5% in Abbott Laboratories (NYSE:ABT).

Other reports by

Discuss This Article